 |
Rajvir Dahiya, PhD
Recent Publications |
Publications – 2008 |
 |
Basak, S., D. Pookot, E.J. Noonan, and
R. Dahiya, Genistein down-regulates androgen receptor by
modulating HDAC6-Hsp90 chaperone function. Mol Cancer Ther,
2008. 7(10): p. 3195-202. |
|
Chen, Z., R.F. Place, Z.J. Jia, D. Pookot,
R. Dahiya, and L.C. Li, Antitumor effect of dsRNA-induced
p21(WAF1/CIP1) gene activation in human bladder cancer cells.
Mol Cancer Ther, 2008. 7(3): p. 698-703. |
|
Hirata, H., Y. Hinoda, N. Okayama,
Y. Suehiro, K. Kawamoto, N. Kikuno, J.T. Rabban, L.M.
Chen, and R. Dahiya, COMT polymorphisms affecting protein
expression are risk factors for endometrial cancer.
Mol Carcinog, 2008. |
|
Hirata, H., Y. Hinoda, N. Okayama, Y. Suehiro, K.
Kawamoto, N. Kikuno, J.T. Rabban, L.M. Chen, and R.
Dahiya, CYP1A1, SULT1A1, and SULT1E1 polymorphisms are
risk factors for endometrial cancer susceptibility.
Cancer, 2008. |
|
Hirata, H., Y. Hinoda, K. Kawamoto,
N. Kikuno, Y. Suehiro, N. Okayama, Y. Tanaka, and R. Dahiya,
Mismatch repair gene MSH3 polymorphism is associated with
the risk of sporadic prostate cancer. J Urol, 2008. 179(5):
p. 2020-4. |
|
Kawamoto, K., H. Hirata, N. Kikuno,
Y. Tanaka, M. Nakagawa, and R. Dahiya, DNA methylation and
histone modifications cause silencing of Wnt antagonist gene
in human renal cell carcinoma cell lines. Int J Cancer, 2008.
123(3): p. 535-42. |
|
Kikuno, N., H. Shiina, S. Urakami, K.
Kawamoto, H. Hirata, Y. Tanaka, S. Majid, M. Igawa, and R.
Dahiya, Genistein mediated histone acetylation and demethylation
activates tumor suppressor genes in prostate cancer cells.
Int J Cancer, 2008. 123(3): p. 552-60. |
|
Kikuno, N., K. Kawamoto, H. Hirata,
K. Vejdani, K. Kawakami, T. Fandel, L. Nunes, S. Urakami,
H. Shiina, M. Igawa, E. Tanagho, and R. Dahiya, Nerve growth
factor combined with vascular endothelial growth factor enhances
regeneration of bladder acellular matrix graft in spinal
cord injury-induced neurogenic rat bladder. BJU Int, 2008. |
|
Majid, S., N. Kikuno, J. Nelles, E.
Noonan, Y. Tanaka, K. Kawamoto, H. Hirata, L.C. Li, H. Zhao,
S.T. Okino, R.F. Place, D. Pookot, and R. Dahiya, Genistein
induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes
in prostate cancer cells by epigenetic mechanisms involving
active chromatin modification. Cancer Res, 2008. 68(8): p.
2736-44. |
|
Place, R.F., L.C. Li, D. Pookot, E.J.
Noonan, and R. Dahiya, MicroRNA-373 induces expression of
genes with complementary promoter sequences. Proc Natl Acad
Sci U S A, 2008. 105(5): p. 1608-13. |
|
Ueno, K., M. Hiura, Y. Suehiro, S.
Hazama, H. Hirata, M. Oka, K. Imai, R. Dahiya, and Y. Hinoda,
Frizzled-7 as a potential therapeutic target in colorectal
cancer. Neoplasia, 2008. 10(7): p. 697-705. |
| |
Publications – 2007 |
|
Hirata, H., Y. Hinoda, N. Kikuno, K.
Kawamoto, A.V. Dahiya, Y. Suehiro, Y. Tanaka, and R.
Dahiya,
CXCL12 G801A polymorphism is a risk factor for sporadic prostate
cancer susceptibility. Clin Cancer Res, 2007. 13(17): p.
5056-62. |
|
Hirata, H., Y. Hinoda, N. Kikuno, K.
Kawamoto, Y. Suehiro, Y. Tanaka, and R. Dahiya, MDM2 SNP309
polymorphism as risk factor for susceptibility and poor prognosis
in renal cell carcinoma. Clin Cancer Res, 2007. 13(14): p.
4123-9. |
|
Hirata, H., Y. Hinoda, Y. Tanaka, N. Okayama,
Y. Suehiro, K. Kawamoto, N. Kikuno, S. Majid, K. Vejdani,
and R. Dahiya, Polymorphisms of DNA repair genes are risk
factors for prostate cancer. Eur J Cancer, 2007. 43(2): p.
231-7. |
|
Kawamoto, K., S.T. Okino, R.F. Place, S.
Urakami, H. Hirata, N. Kikuno, T. Kawakami, Y. Tanaka, D.
Pookot, Z. Chen, S. Majid, H. Enokida, M. Nakagawa, and
R. Dahiya, Epigenetic modifications of RASSF1A gene through chromatin remodeling
in prostate cancer. Clin Cancer Res, 2007. 13(9): p. 2541-8. |
|
Kikuno, N., H. Shiina, S. Urakami, K. Kawamoto,
H. Hirata, Y. Tanaka, R.F. Place, D. Pookot, S. Majid, M.
Igawa, and R. Dahiya, Knockdown of astrocyte-elevated gene-1
inhibits prostate cancer progression through upregulation
of FOXO3a activity. Oncogene, 2007. 26(55): p. 7647-55. |
|
Li, L.C. and R. Dahiya, Epigenetics of prostate
cancer. Front Biosci., 2007. May 1(12): p. 3377-97. |
|
Okino, S.T., D. Pookot, S. Majid, H.
Zhao, L.C. Li, R.F. Place, and R. Dahiya, Chromatin changes
on the GSTP1 promoter associated with its inactivation in
prostate cancer. Mol Carcinog, 2007. 46(10): p. 839-46. |
|
Okino, S.T., L.C. Quattrochi, D. Pookot,
M. Iwahashi, and R. Dahiya, A dioxin-responsive enhancer
3' of the human CYP1A2 gene. Mol Pharmacol, 2007. 72(6):
p. 1457-65. |
|
Qin, J., L.P. Xie, X.Y. Zheng, Y.B. Wang,
Y. Bai, H.F. Shen, L.C. Li, and R. Dahiya, A component of
green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis
in T24 human bladder cancer cells via modulation of the PI3K/Akt
pathway and Bcl-2 family proteins. Biochem Biophys Res Commun,
2007. 354(4): p. 852-7. |
|
Tanaka, Y., H. Hirata, Z. Chen, N. Kikuno,
K. Kawamoto, S. Majid, T. Tokizane, S. Urakami, H. Shiina,
K. Nakajima, R. Dhir, and R. Dahiya, Polymorphisms of catechol-O-methyltransferase
in men with renal cell cancer. Cancer Epidemiol Biomarkers
Prev, 2007. 16(1): p. 92-7. |
|
Urakami, S., H. Shiina, H. Enokida,
K. Kawamoto, N. Kikuno, T. Fandel, K. Vejdani, L. Nunes,
M. Igawa, E.A. Tanagho, and R. Dahiya, Functional improvement
in spinal cord injury-induced neurogenic bladder by bladder
augmentation using bladder acellular matrix graft in the
rat. World J Urol, 2007. 25(2): p. 207-13. |
| |
return
to top
|
|
|
|
|
|
